166 related articles for article (PubMed ID: 25736189)
1. Hypogonadism and fertility issues following primary treatment for testicular cancer.
Oldenburg J
Urol Oncol; 2015 Sep; 33(9):407-12. PubMed ID: 25736189
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadism risk in men treated for childhood cancer.
Romerius P; Ståhl O; Moëll C; Relander T; Cavallin-Ståhl E; Wiebe T; Giwercman YL; Giwercman A
J Clin Endocrinol Metab; 2009 Nov; 94(11):4180-6. PubMed ID: 19789207
[TBL] [Abstract][Full Text] [Related]
3. Hypogonadism and infertility in testicular cancer survivors.
Jacobs LA; Vaughn DJ
J Natl Compr Canc Netw; 2012 Apr; 10(4):558-63. PubMed ID: 22491052
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
5. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
Nord C; Bjøro T; Ellingsen D; Mykletun A; Dahl O; Klepp O; Bremnes RM; Wist E; Fosså SD
Eur Urol; 2003 Sep; 44(3):322-8. PubMed ID: 12932930
[TBL] [Abstract][Full Text] [Related]
6. Gonadal function in men with testicular cancer.
Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
[TBL] [Abstract][Full Text] [Related]
7. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.
Bogefors C; Isaksson S; Bobjer J; Kitlinski M; Leijonhufvud I; Link K; Giwercman A
Andrology; 2017 Jul; 5(4):711-717. PubMed ID: 28544654
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell Dysfunction.
Skøtt JW; Lauritsen J; Kreiberg M; Daugaard G; Bandak M
Clin Genitourin Cancer; 2019 Feb; 17(1):e65-e71. PubMed ID: 30293923
[TBL] [Abstract][Full Text] [Related]
12. The influence of hormonal treatment with beta-human chorionic gonadotropin for cryptorchidism on future fertility in rats.
Yilmaz Ö; Akyol İ; Özyurt M; Ateş F; Soydan H; Malkoç E
J Pediatr Urol; 2015 Apr; 11(2):92.e1-4. PubMed ID: 25819376
[TBL] [Abstract][Full Text] [Related]
13. Fertility, gonadal and sexual function in survivors of testicular cancer.
Huddart RA; Norman A; Moynihan C; Horwich A; Parker C; Nicholls E; Dearnaley DP
Br J Cancer; 2005 Jul; 93(2):200-7. PubMed ID: 15999104
[TBL] [Abstract][Full Text] [Related]
14. Paternity following treatment for testicular cancer.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O
J Natl Cancer Inst; 2005 Nov; 97(21):1580-8. PubMed ID: 16264178
[TBL] [Abstract][Full Text] [Related]
15. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129
[TBL] [Abstract][Full Text] [Related]
16. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
17. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
18. Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Eur J Cancer; 2017 Oct; 84():9-17. PubMed ID: 28772110
[TBL] [Abstract][Full Text] [Related]
19. Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer.
Ondrusova M; Ondrus D; Dusek L; Spanikova B
Neoplasma; 2009; 56(6):473-9. PubMed ID: 19728753
[TBL] [Abstract][Full Text] [Related]
20. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer.
Mykletun A; Dahl AA; Haaland CF; Bremnes R; Dahl O; Klepp O; Wist E; Fosså SD
J Clin Oncol; 2005 May; 23(13):3061-8. PubMed ID: 15860864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
